IP Library Granted Patent US 7,648,958
Granted Patent B2
US 7,648,958 · App. 10/789,562 · Granted Jan 19, 2010

Factor VIII/vWF-complex and methods of purifying same

Assignee: Baxter Innovations GmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,648,958
App. No.
10/789,562
Granted
Jan 19, 2010
Kind
B2
Abstract

There is disclosed a method of recovering factor VIII/vWF-complex which is characterized in that factor VIII/vWF-complex from a protein solution is bound to a cation exchanger and is recovered by step-wise elution of factor VIII/vWF-complex, which particularly contains high-molecular vWF multimers, as well as a factor VIII/vWF-complex obtainable by means of cation exchange chromatography.

Claims (5)

1. An isolated protein fraction comprising Factor VIII:C that is free of measurable platelet agglutinating vWF activity, as determined by measuring vWF:Risto-CoF activity, wherein the protein fraction is obtained from a Factor VIII/vWF-containing solution by cation exchange chromatography and step-wise elution at a salt concentration of between >200 mM and <300 mM, and wherein the Factor VIII/vWF-containing solution is a cryoprecipitate, a supernatant, or an extract of a recombinant cell culture.

2. A preparation comprising the Factor VIII:C of claim 1 , wherein said preparation is virus safe and free from infectious material.

3. The preparation of claim 2 , wherein said preparation is present in storage-stable form.

4. The preparation of claim 2 , wherein said preparation is formulated in a buffer.

5. A method of treating patients suffering from Hemophilia A, Phenotypic Hemophilia or von Willebrand Disease (vWD), comprising administering to said patients an effective amount of the Factor VIII:C of claim 1 .

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR NAME, EXECUTION DATE, AND ADDRESS OF ASSIGNEE BAXALTA GMBH PREVIOUSLY RECORDED ON REEL 036366 FRAME 0301. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Mar 31, 2016
From: BAXALTA INNOVATIONS GMBH
To: BAXALTA INCORPORATED; BAXALTA GMBH
Reel/Frame 038324/0691 →
CHANGE OF NAME Recorded Mar 29, 2016
From: BAXTER INNOVATIONS GMBH
To: BAXALTA INNOVATIONS GMBH
Reel/Frame 038292/0838 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2015
From: BAXTER INNOVATIONS GMBH
To: BAXALTA GMBH; BAXALTA INCORPORATED
Reel/Frame 036366/0301 →
CHANGE OF NAME Recorded Dec 4, 2009
From: BAXTER AKTIENGESELLSCHAFT
To: BAXTER INNOVATIONS GMBH
Reel/Frame 023607/0846 →
Priority Claims (1)
AU 338/97 · Feb 27, 1997 · national
Continuity (2)
Division 0936745900
Related Publication 20050239171A1 · Oct 27, 2005